Dun & Bradstreet [DNB] vs CME [CME] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Dun & Bradstreet Holdings, Inc. wins in 5 metrics, CME Group Inc. wins in 14 metrics, with 0 ties. CME Group Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Dun & Bradstreet Holdings, Inc. | CME Group Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -130.71 | 24.34 | CME Group Inc. |
| Price-to-Book Ratio | 1.23 | 3.57 | Dun & Bradstreet Holdings, Inc. |
| Debt-to-Equity Ratio | 106.76 | 12.86 | CME Group Inc. |
| PEG Ratio | -1.31 | 1.03 | CME Group Inc. |
| EV/EBITDA | 12.02 | 21.55 | Dun & Bradstreet Holdings, Inc. |
| Profit Margin (TTM) | -1.60% | 63.31% | CME Group Inc. |
| Operating Margin (TTM) | 3.54% | 69.66% | CME Group Inc. |
| EBITDA Margin (TTM) | 3.54% | 69.66% | CME Group Inc. |
| Return on Equity | -1.03% | 15.92% | CME Group Inc. |
| Return on Assets (TTM) | 1.60% | 1.55% | Dun & Bradstreet Holdings, Inc. |
| Free Cash Flow (TTM) | $223.00M | $4.19B | CME Group Inc. |
| Dividend Yield | N/A | 4.11% | N/A |
| 1-Year Return | -23.75% | -5.35% | CME Group Inc. |
| Price-to-Sales Ratio (TTM) | 1.70 | 15.36 | Dun & Bradstreet Holdings, Inc. |
| Enterprise Value | $7.37B | $103.28B | CME Group Inc. |
| EV/Revenue Ratio | 3.06 | 15.31 | Dun & Bradstreet Holdings, Inc. |
| Gross Profit Margin (TTM) | 58.58% | N/A | N/A |
| Revenue per Share (TTM) | $6 | $19 | CME Group Inc. |
| Earnings per Share (Diluted) | $-0.09 | $11.73 | CME Group Inc. |
| Beta (Stock Volatility) | 1.12 | 0.30 | CME Group Inc. |
| Short % of Float | 5.04% | 1.44% | CME Group Inc. |
Dun & Bradstreet Holdings, Inc. vs CME Group Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dun & Bradstreet Holdings, Inc. | 0.44% | 0.55% | 0.33% | 1.67% | 6.03% | 6.03% |
| CME Group Inc. | 0.84% | -11.33% | -13.70% | -23.26% | -9.72% | -7.10% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dun & Bradstreet Holdings, Inc. | -23.75% | -35.38% | -62.90% | -66.24% | -66.24% | -66.24% |
| CME Group Inc. | -5.35% | 47.62% | 25.26% | 182.55% | 402.74% | 200.07% |
Performance & Financial Health Analysis: Dun & Bradstreet Holdings, Inc. vs CME Group Inc.
| Metric | DNB | CME |
|---|---|---|
| Market Information | ||
| Market Cap | $4.08B | $103.42B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 5,208,239 | 2,489,654 |
| 90 Day Avg. Volume | 3,454,586 | 2,270,221 |
| Last Close | $9.15 | $252.64 |
| 52 Week Range | $7.78 - $12.94 | $244.56 - $329.16 |
| % from 52W High | -29.32% | -23.25% |
| All-Time High | $29.55 (Nov 02, 2020) | $329.16 (Mar 03, 2026) |
| % from All-Time High | -69.04% | -23.25% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.15% |
| Quarterly Earnings Growth | 0.02% | 0.21% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.63% |
| Operating Margin (TTM) | 0.04% | 0.70% |
| Return on Equity (TTM) | -0.01% | 0.16% |
| Debt to Equity (MRQ) | 106.76 | 12.86 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.41 | $80.03 |
| Cash per Share (MRQ) | $0.64 | $7.56 |
| Operating Cash Flow (TTM) | $454.50M | $4.54B |
| Levered Free Cash Flow (TTM) | $593.36M | $4.11B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 4.11% |
| Last 12-Month Dividend | N/A | $12.45 |
Valuation & Enterprise Metrics Analysis: Dun & Bradstreet Holdings, Inc. vs CME Group Inc.
| Metric | DNB (Sep 10, 2025) | CME (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -130.71 | 24.34 |
| Forward P/E | 8.24 | 22.14 |
| PEG Ratio | -1.31 | 1.03 |
| Price to Sales (TTM) | 1.70 | 15.36 |
| Price to Book (MRQ) | 1.23 | 3.57 |
| Market Capitalization | ||
| Market Capitalization | $4.08B | $103.42B |
| Enterprise Value | $7.37B | $103.28B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.06 | 15.31 |
| Enterprise to EBITDA | 12.02 | 21.55 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 0.30 |
| Book Value per Share (MRQ) | $7.41 | $80.03 |
Financial Statements Comparison: Dun & Bradstreet Holdings, Inc. vs CME Group Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | DNB (2024) | CME (2025) |
|---|---|---|
| Revenue/Sales | 2.38B | 6.52B |
| Cost of Goods Sold | 899.70M | 907.00M |
| COGS % of Revenue | 37.8% | 13.9% |
| Gross Profit | 1.48B | 5.61B |
| Gross Margin | 62.2% | 86.1% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 211.70M | 4.23B |
| Operating Margin | 8.9% | 64.9% |
| EBITDA | 796.90M | 98.30M |
| EBITDA Margin | 33.5% | 1.5% |
| Pre-Tax Income | -61.30M | 5.33B |
| Pre-Tax Income % of Revenue | -2.6% | 81.7% |
| Income Tax | -33.70M | 1.26B |
| Income Tax % of Revenue | -1.4% | 19.3% |
| Net Income (Profit) | -24.50M | 4.07B |
| Profit Margin | -1.0% | 62.5% |
Balance Sheet & Liquidity Metrics
| Metric | DNB (2024) | CME (2025) |
|---|---|---|
| Cash & Equivalents | 205.90M | 4.42B |
| Total Current Assets | 650.40M | 165.36B |
| Total Current Assets % of Revenue | 27.3% | 2,536.0% |
| Total Current Liabilities | 1.01B | 160.30B |
| Total Current Liabilities % of Revenue | 42.3% | 2,458.3% |
| Long-Term Debt | 3.53B | 3.42B |
| Long-Term Debt % of Revenue | 148.2% | 52.5% |
| Total Shareholders Equity | 3.31B | 28.73B |
| Retained Earnings | -839.70M | 6.43B |
| Retained Earnings % of Revenue | -35.3% | 98.7% |
| Property, Plant & Equipment | 42.60M | 0 |
Cash Flow Statement Comparison
| Metric | DNB (2024) | CME (2025) |
|---|---|---|
| Operating Cash Flow | 403.40M | 4.54B |
| Operating Cash Flow % of Revenue | 16.9% | 69.6% |
| Capital Expenditures | N/A | -83.50M |
| Free Cash Flow | 223.00M | 4.19B |
| FCF Margin | 9.4% | 64.3% |
| Debt Repayment | -3.71B | -750.00M |
| Common Stock Repurchase | -9.30M | -266.10M |
Short Interest & Institutional Ownership Analysis
| Metric | DNB | CME |
|---|---|---|
| Shares Short | 17.88M | 4.70M |
| Short Ratio | 6.53 | 2.28 |
| Short % of Float | 5.04% | 1.44% |
| Shares Outstanding | 441.55M | 362.80M |
| Float Shares | 315.39M | 357.72M |
| % Held by Insiders | 9.42% | 0.48% |
| % Held by Institutions | 90.23% | 91.89% |
| % Held by Public | 0.35% | 7.63% |
Dividend Analysis & Yield Comparison: Dun & Bradstreet Holdings, Inc. vs CME Group Inc.
| Metric | DNB | CME |
|---|---|---|
| Last 12-Month Dividend | N/A | $12.45 |
| Last 12-Month Dividend Yield | N/A | 4.11% |
| 3-Year Avg Annual Dividend | N/A | $10.83 |
| 3-Year Avg Dividend Yield | N/A | 0.92% |
| 3-Year Total Dividends | N/A | $32.50 |
| Ex-Dividend Date | N/A | Mar 10, 2026 |